342 related articles for article (PubMed ID: 18773958)
1. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.
Orlando G; Manzia T; Baiocchi L; Sanchez-Fueyo A; Angelico M; Tisone G
Transpl Immunol; 2008 Nov; 20(1-2):43-7. PubMed ID: 18773958
[TBL] [Abstract][Full Text] [Related]
2. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
Tisone G; Orlando G; Cardillo A; Palmieri G; Manzia TM; Baiocchi L; Lionetti R; Anselmo A; Toti L; Angelico M
J Hepatol; 2006 Apr; 44(4):702-9. PubMed ID: 16473433
[TBL] [Abstract][Full Text] [Related]
3. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
4. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
[TBL] [Abstract][Full Text] [Related]
5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
6. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
[TBL] [Abstract][Full Text] [Related]
7. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.
Manzia TM; Angelico R; Baiocchi L; Toti L; Ciano P; Palmieri G; Angelico M; Orlando G; Tisone G
Transpl Int; 2013 Mar; 26(3):259-66. PubMed ID: 23278973
[TBL] [Abstract][Full Text] [Related]
8. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
10. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
11. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
13. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
[TBL] [Abstract][Full Text] [Related]
15. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
Ghabril M; Dickson RC; Machicao VI; Aranda-Michel J; Keaveny A; Rosser B; Bonatti H; Krishna M; Yataco M; Satyanarayana R; Harnois D; Hewitt W; Willingham DD; Grewal H; Hughes CB; Nguyen J
Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of immunosuppression withdrawal after liver transplantation.
Girlanda R; Rela M; Williams R; O'Grady JG; Heaton ND
Transplant Proc; 2005 May; 37(4):1708-9. PubMed ID: 15919439
[TBL] [Abstract][Full Text] [Related]
17. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation.
Di Benedetto F; Di Sandro S; De Ruvo N; Montalti R; Ballarin R; Guerrini GP; Spaggiari M; Guaraldi G; Gerunda G
Transplantation; 2010 Mar; 89(6):733-8. PubMed ID: 20048692
[TBL] [Abstract][Full Text] [Related]
18. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
[TBL] [Abstract][Full Text] [Related]
20. Predictors of patient and graft survival following liver transplantation for hepatitis C.
Charlton M; Seaberg E; Wiesner R; Everhart J; Zetterman R; Lake J; Detre K; Hoofnagle J
Hepatology; 1998 Sep; 28(3):823-30. PubMed ID: 9731579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
